By Marcia Dunn

NASA is returning to sizzling Venus, our closest yet perhaps most overlooked neighbor, after decades of exploring other worlds.

The space agency's new administrator, Bill Nelson, announced two new robotic missions to the solar system's hottest planet, during his first major address to employees Wednesday.

“These two sister missions both aim to understand how Venus became an inferno-like world capable of melting lead at the surface," Nelson said.

One mission named DaVinci Plus will analyze the thick, cloudy Venusian atmosphere in an attempt to determine whether the inferno planet ever had an ocean and was possibly habitable. A small craft will plunge through the atmosphere to measure the gases.

It will be the first U.S.-led mission to the Venusian atmosphere since 1978.

The other mission, called Veritas, will seek a geologic history by mapping the rocky planet’s surface.

“It is astounding how little we know about Venus," but the new missions will give fresh views of the planet's atmosphere, made up mostly of carbon dioxide, down to the core, NASA scientist Tom Wagner said in a statement. “It will be as if we have rediscovered the planet.”

NASA’s top science official, Thomas Zurbuchen, calls it “a new decade of Venus.” Each mission — launching sometime around 2028 to 2030 — will receive $500 million for development under NASA’s Discovery program.

The missions beat out two other proposed projects, to Jupiter's moon Io and Neptune's icy moon Triton.

The U.S. and the former Soviet Union sent multiple spacecraft to Venus in the early days of space exploration. NASA's Mariner 2 performed the first successful flyby in 1962, and the Soviets' Venera 7 made the first successful landing in 1970.

In 1989, NASA used a space shuttle to send its Magellan spacecraft into orbit around Venus.

The European Space Agency put a spacecraft around Venus in 2006.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
New BA.2 Variant Predicted to Boost Covid Cases in U.S.
A subvariant of the omicron COVID-19 variant called BA.2 is causing an outbreak overseas. Now, some health experts worry it could also lead to an increase in COVID-19 cases in the U.S. Dr. Amesh Adalja, infectious disease specialist and senior scholar at Johns Hopkins Center for Health Security, joins Cheddar News to discuss.
Green Battery Materials Maker Nouveau Monde Graphite Aims to Power Energy Revolution
Nouveau Monde Graphite says it wants to power the sustainable energy revolution. The Canadian company is developing carbon-neutral battery materials to serve the growing EV and cleantech markets and is doing so via a mining and manufacturing operation in Quebec. Eric Desaulniers, founder, president & CEO of Nouveau Monde Graphite, joins Cheddar News' Closing Bell to discuss.
There's A New Subvariant. How Concerned Should We Be?
Health experts are warning an even more contagious subvariant of Omicron, known as BA.2, could soon lead to another surge in Covid cases here in the U.S. The variant has already driven cases to skyrocket in China and Europe, which has historically served as a preview to the pattern the U.S. has seen throughout the pandemic. This comes at a time when protection from booster shots is waning for most people who got them. Dr. Jen Caudle, Family Physician & Associate Professor at Rowan University, explains what we can do to protect ourselves against the new variant and how we should act as warnings of another surge rise.
Cresco Labs to Become the Largest U.S. Cannabis Company by Sales With Columbia Care Acquisition
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Breaking Down Moderna Seeking COVID Vaccine Approval for Kids Under 6
Moderna announced it's seeking emergency use approval for its COVID-19 vaccine from the FDA for children under 6 years old. A former FDA associate commissioner and the president and co-founder of the Center for Medicine in the Public Interest (CMPI) Peter Pitts joined Cheddar News to talk about the timeline, benefits, and risks that come with the approval of the vaccine. "We want to protect their parents and their grandparents and their caregivers and their daycare providers, so it's all about protecting not just the kids but all around the people that are surrounding those kids," he said.
Load More